Jarrow Formulas Ginkgo Biloba 50:1, 60 mg Review

It's 60 mg per capsule. The clinical dose of 120 mg/day requires two capsules. This is the single most important thing to understand before buying: the live Amazon listing labels it '60 MG,' and the per-serving math is on you. If you want the trial-standard 120 mg dose (the one behind Le Bars 1997 and most ginkgo evidence), you take two Jarrow capsules. If you want a gentler 60 mg dose, you take one. The flexibility is the point of this product, but it also means a careless shopper could under-dose by taking just one capsule and thinking they're at the clinical dose. Read the label and do the math.

For dosing flexibility. A 60 mg capsule lets you titrate: start at a gentle 60 mg/day to assess tolerance, then step up to 120 mg (two capsules) if you want the full clinical dose. Some people prefer easing into a botanical, or splitting their dose across the day (one capsule morning, one evening). If you specifically value that granular control, the 60 mg cap is useful. If you just want the trial-standard 120 mg in one go, a 120 mg-per-capsule product (Doctor's Best #1, NOW #3) is simpler and more efficient — no doubling up.

Effectively yes, at the clinical dose. The bottle is cheap (~$13), but because you need two capsules for 120 mg, a 120-count bottle is only a two-month supply at the clinical dose — about twenty-two cents per 120 mg serving. That's still reasonable, but it's pricier per effective day than the one-capsule 120 mg picks, and the bottle empties twice as fast as the count suggests. If you run the gentle 60 mg dose (one capsule), the bottle lasts four months and the per-day cost halves — so the value depends entirely on which dose you take.

Yes — the extract spec itself is solid. Jarrow uses a 50:1 extract standardised to 24% ginkgoflavonglycosides (the same as flavone glycosides) and 6% terpene lactones — the full EGb 761-class spec, the same standardisation as the higher-ranked picks. It's also free from major allergens (wheat, gluten, soy, dairy, egg, nuts) from an established value brand. The extract quality isn't why it ranks lower; the two-capsule dosing and the potentially-confusing '60 MG' label are. On spec alone, it's right there with the leaders.

The same modest, honest outcome as any well-standardised ginkgo — provided you actually take the clinical dose. If you run 120 mg/day (two capsules) consistently for 6-8 weeks, you're where the evidence sits: standardised ginkgo has shown modest memory and circulation benefit in people with measurable impairment (Le Bars 1997; Herrschaft 2012; Pittler & Ernst 2000). It does not prevent decline in healthy people (GEM Study, DeKosky 2008). The one pitfall unique to this product: if you take only one capsule (60 mg) thinking it's the full dose, you're under-dosing — so mind the math, then judge it patiently.

1. [1] Le Bars 1997 PMID 9343463 — A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. 52-week RCT of standardised EGb 761 (120 mg/day) in dementia: modest cognitive/functional benefit vs placebo. The 120 mg dose here requires two Jarrow capsules.
2. [2] Herrschaft 2012 PMID 22459264 — Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. 24-week RCT, 410 patients: 240 mg/day EGb 761 beat placebo on cognition and neuropsychiatric symptoms. Confirms standardised ginkgo's symptomatic benefit at the upper dose end.
3. [3] DeKosky 2008 (GEM Study) PMID 19017911 — Ginkgo biloba for prevention of dementia: a randomized controlled trial. GEM Study: 3,069 older adults, ~6 years, 240 mg/day vs placebo — ginkgo did NOT prevent dementia. The honesty caveat for every ginkgo, this one included.